Sökning: onr:"swepub:oai:DiVA.org:umu-16124" >
Conversion towards ...
-
Rantapää-Dahlqvist, SolbrittUmeå universitet,Institutionen för folkhälsa och klinisk medicin
(författare)
Conversion towards an atherogenic lipid profile in rheumatoid arthritis patients during long-term infliximab therapy.
- Artikel/kapitelEngelska2006
Förlag, utgivningsår, omfång ...
-
2009-08-25
-
Informa UK Limited,2006
-
printrdacarrier
Nummerbeteckningar
-
LIBRIS-ID:oai:DiVA.org:umu-16124
-
https://urn.kb.se/resolve?urn=urn:nbn:se:umu:diva-16124URI
-
https://doi.org/10.1080/03009740500474578DOI
Kompletterande språkuppgifter
-
Språk:engelska
-
Sammanfattning på:engelska
Ingår i deldatabas
Klassifikation
-
Ämneskategori:ref swepub-contenttype
-
Ämneskategori:art swepub-publicationtype
Anmärkningar
-
OBJECTIVES: To analyse the effects of infliximab infusions on serum levels of lipids in patients with rheumatoid arthritis (RA) treated for 2 years. METHODS: Fifty-two patients (41 females and 11 males) with RA undergoing infliximab treatment (3 mg/kg) were consecutively recruited into the study. The mean (+/-SD) age of the patients was 54.6+/-12.5 years and mean disease duration was 14.1+/-8.6 years. Blood was sampled before infusion at baseline, and at 3, 6, 12, 18 and 24 months. Forty-one of the patients were also treated with methotrexate, 13 with other disease-modifying anti-rheumatic drugs (DMARDs) and 28 with prednisolone (<10 mg daily). For comparison, lipid levels were followed for 2 years in 70 consecutively included patients with early RA during treatment with conventional DMARDs. RESULTS: There was an initial increase in plasma levels of cholesterol, high density lipoprotein (HDL)-cholesterol, low density lipoprotein (LDL)-cholesterol, and LDL/HDL and total/HDL cholesterol ratios. However, after 3 months HDL-cholesterol decreased significantly, followed after 6 months by cholesterol and LDL-cholesterol. The LDL/HDL and total/HDL-cholesterol ratios remained significantly raised. HDL-cholesterol increased and the ratios improved in patients with early RA receiving conventional treatment. The changes over time differed significantly between the patient groups. CONCLUSION: During infliximab infusion a pro-atherogenic lipid profile developed despite reduced inflammatory activity. The long-term decrease in HDL-cholesterol was unexpected considering the known effects of tumour necrosis factor-alpha (TNFalpha).
Biuppslag (personer, institutioner, konferenser, titlar ...)
-
Engstrand, S
(författare)
-
Berglin, EvaUmeå universitet,Institutionen för folkhälsa och klinisk medicin(Swepub:umu)evbe0009
(författare)
-
Johnson, OweUmeå universitet,Institutionen för folkhälsa och klinisk medicin(Swepub:umu)ovjo0001
(författare)
-
Umeå universitetInstitutionen för folkhälsa och klinisk medicin
(creator_code:org_t)
Sammanhörande titlar
-
Ingår i:Scand J Rheumatol: Informa UK Limited35:2, s. 107-11
-
Ingår i:Scandinavian Journal of Rheumatology: Informa UK Limited35:2, s. 107-110300-97421502-7732
Internetlänk
Hitta via bibliotek
Till lärosätets databas